首页> Recent patents on anti-cancer drug discovery> Novel Small Molecule Inhibitors of Programmed Cell Death (PD)-1, and its Ligand, PD-L1 in Cancer Immunotherapy: A Review Update of Patent Literature

Novel Small Molecule Inhibitors of Programmed Cell Death (PD)-1, and its Ligand, PD-L1 in Cancer Immunotherapy: A Review Update of Patent Literature

导出原文传递

翻译打印收藏纠错

第一作者： Kopalli, Spandana R.

作者： Kopalli, Spandana R. ^[1] ; Kang, Tae-Bong ^[2] ; Lee, Kwang-Ho ; Koppula, Sushruta

作者单位： Sejong Univ, Dept Biosci & Biotechnol, Seoul 05006, South Korea ^[1] Konkuk Univ, Coll Biomed & Hlth Sci, Chungju 27478, South Korea ^[2]

关键词 Cancer immune checkpoints immunomodulatory immunotherapy peptidomimetic PD-1/PDL-1 signaling

发布时间 2019-12-13

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Recent patents on anti-cancer drug discovery

2019年14卷2期

100-112页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

Recent patents on anti-cancer drug discovery

2019年14卷2期

100-112页

检索历史清除

Novel Small Molecule Inhibitors of Programmed Cell Death (PD)-1, and its Ligand, PD-L1 in Cancer Immunotherapy: A Review Update of Patent Literature

Recent patents on anti-cancer drug discovery

相似文献

同项目论文

Recent patents on anti-cancer drug discovery

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Novel Small Molecule Inhibitors of Programmed Cell Death (PD)-1, and its Ligand, PD-L1 in Cancer Immunotherapy: A Review Update of Patent Literature

Recent patents on anti-cancer drug discovery

相似文献

同项目论文

Recent patents on anti-cancer drug discovery

相关期刊

检索历史清除